PK Study of PT003 and PT001 in Japanese Healthy Subjects

Trial Identifier:	PT003010-00
Sponsor:	Pearl Therapeutics, Inc.
NCTID:	NCT02196714
Start Date:	July 2014
Primary Completion Date:	September 2014
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country	Location
USA, MD	Baltimore, MD, USA, 21201

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.